QUAZI AL-TARIQ: Open Payments
NPI 1124033808 · MIDDLETOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 42 payments from 7 companies in 2025. Trend: 2023 $1,381 · 2024 $1,093 · 2025 $759
Food & beverage: $748Education: $11
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $248 |
| Janssen Pharmaceuticals, Inc | 14 | $171 |
| Otsuka America Pharmaceutical, Inc. | 14 | $154 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: INVEGA SUSTENNA, LYBALVI, UZEDY, ARISTADA, ABILIFY ASIMTUFII, REXULTI, TRINTELLIX, CAPLYTA.
Industry payments across NY — which companies pay providers there.
